Autoimmune Blistering Diseases Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Pennsylvania
About this trial
Pemphigus and bullous pemphigoid (BP) are severe autoimmune blistering diseases (AIBD) that pose a critical need for new therapeutic approaches. Clinical trials in pemphigus and BP will require the availability of validated disease severity measures that can be used to define primary outcomes.
Eligibility criteria
Qualifiers
Gender/Age: Males or females above 18 years old
Diagnosis: pemphigus vulgaris, pemphigus foliaceus, bullous pemphigoid
Subjects able to give informed consent
Disqualifiers
Patients who are under age 18 years.
Patients without pemphigus or pemphigoid diseases
Penn employees
Penn students
Trial design
Treatments tested in this trial
- Questionnaires
Treatment groups
No treatment groups listed
Locations
3Hospital of the University of Pennsylvania19104, PhiladelphiaPennsylvania, United States
Hospital of the University of Pennsylvania, Department of Dermatology19104, PhiladelphiaPennsylvania, United States
University of Pennsylvania, Department of Dermatology19104, PhiladelphiaPennsylvania, United States
Sponsors and collaborators
University of Pennsylvania
Lead sponsor
Source ClinicalTrials.gov